551 results for "Integration Therapy"
Finding the divine within: exploring the role of the sacred in psychedelic integration therapy for sexual trauma and dysfunction
Sexual & Relationship Therapy – October 20, 2021
Summary
Psychedelic integration therapy offers remarkable healing for human sexuality and trauma. Guided by a psychotherapist, individuals using natural compounds like psilocybin report profound embodied pleasure, liberated from shame. This psychological approach fosters a healthy identity and increased sexual satisfaction, addressing deep-seated issues that can underpin addiction. Clients describe direct, existential meaning through divine connection, facilitating sustained well-being. This innovative area within psychedelics and drug studies holds significant promise.
Abstract
During the last two decades, psychedelic-assisted therapy has emerged as one of the most promising novel treatments for depression, anxiety, PTSD, ...
Effect of Heartfulness meditation based integrative therapy on infertility outcomes: A retrospective case series evaluation.
Journal of Ayurveda and integrative medicine – January 01, 2023
Summary
No Summary
Abstract
In Indian context, infertility is often a silent struggle. Despite the high prevalence of infertility in the country, the majority of couples do no...
Ethical and legal issues in psychedelic harm reduction and integration therapy
Harm Reduction Journal – April 11, 2021
Summary
Despite legal restrictions, growing interest in psychedelic-assisted therapy leads many to explore psychedelics independently. This creates an ethical duty for therapists to provide support. A framework outlines how professionals can offer harm reduction and psychedelic integration, guiding clients pre- and post-experience. This approach helps minimize risks and maximize benefits, ensuring ethical practice for those navigating personal use of psychedelics.
Abstract
Abstract Psychedelic-assisted therapy may represent an upcoming paradigm shift in the treatment of mental health problems as recent clinical trials...
Mystical experience occasioned by non-medicinal embodied therapy And integration process for mental well-Being
OpenAlex – December 22, 2022
Summary
Over half of participants (51%) in an embodied cognition program reported strong mystical experiences, mirroring effects seen with hallucinogens like Psilocybin. An additional 31% experienced moderate effects. This exploratory research involved 56 individuals undergoing a Body Logic Program, designed to integrate body and mind. Such findings in psychology and psychiatry suggest new avenues for mental health support, potentially offering psychotherapists novel medicine approaches without traditional psychedelics. This could be significant for mental health and psychiatry, especially in body image and dysmorphia studies, as an alternative to drug studies.
Abstract
Expansion of psychoactive hallucinogens in mental health continues to be a major trend. Several psychoactive molecules including psilocybin and MDM...
An Integrative Approach to Ketamine Therapy May Enhance Multiple Dimensions of Efficacy: Improving Therapeutic Outcomes With Treatment Resistant Depression.
Front Psychiatry – November 24, 2021
Summary
For those battling severe depression, integrating ketamine therapy with other supportive treatments, like psychotherapy, dramatically enhances its benefits. This combined strategy improves various dimensions of well-being, leading to significantly better and more comprehensive therapeutic outcomes for individuals with treatment-resistant depression.
Abstract
An Integrative Approach to Ketamine Therapy May Enhance Multiple Dimensions of Efficacy: Improving Therapeutic Outcomes With Treatment Resistant De...
Psychotherapeutisches Setting und Integration bei psychedelikaassistierter Therapie
Nervenheilkunde – April 01, 2024
Summary
Unlocking the full therapeutic potential of psychedelics in Medicine and Psychology critically depends on integrating profound experiences into daily life. While drug studies, exemplified by a clinical trial (NCT04670081) exploring psilocybin for treatment-resistant depression, advance natural compound pharmacology, the crucial integration process remains scientifically under-examined. Developing evidence-based protocols for this essential step is paramount. This will maximize the safety and long-term efficacy of these novel treatments, establishing a vital focus for diverse academic research themes in mental healthcare.
Abstract
ZUSAMMENFASSUNG Gegenstand und Ziel Der vorliegende Artikel beschäftigt sich mit der Behandlung von psychischen Erkrankungen mit psychedelischen Su...
Increased global integration in the brain after psilocybin therapy for depression.
Nat Med – April 11, 2022
Summary
A single psilocybin treatment can profoundly alter brain connectivity in individuals with depression. Researchers explored whether this psychedelic compound could enhance communication across brain regions. Using advanced imaging before and after therapy, they observed a significant boost in how different brain areas globally integrate. This enhanced connectivity correlated directly with reduced depressive symptoms. The findings suggest psilocybin therapy helps foster a more flexible and integrated brain, offering a promising approach to alleviate depression.
Abstract
Increased global integration in the brain after psilocybin therapy for depression.
A Perspective for Enhancing the Supervision of Psychedelic-Assisted Therapy: Motivational-Interviewing-Enhanced Integration Supervision (MIE-IS)
Psychoactives – June 25, 2025
Summary
Traditional clinical supervision often has limited impact on therapy outcomes. A novel model proposes that supervisors, by modeling Motivational Interviewing (MI) principles within supervisory relationships, can significantly enhance psychedelic-assisted therapy. This approach empowers trainees to effectively guide clients through crucial psychedelic integration, translating insights into lasting behavioral change. It fosters skill development, improves client outcomes, and promotes self-care, enhancing the overall efficacy of clinical supervision.
Abstract
While research on psychedelic-assisted therapy (PAT) continues to show promise, challenges in its clinical application persist. One relevant domain...
Expert recommendations for Germany’s integration of psychedelic-assisted therapy
BMC Medical Education – October 24, 2024
Summary
Australia has already approved MDMA and psilocybin for mental health, highlighting Europe's urgent need to advance medical education in psychedelic-assisted therapy. With USA trials in Phase III, Germany is poised to lead Europe in developing robust frameworks for integrating innovative Psychedelics and Drug Studies into Medicine. This includes defining ethical Psychotherapy Techniques and Applications, practitioner training, and regulatory oversight. Such infrastructure development aims to ensure proficient care, potentially reclaiming Europe's historical lead in Psychology and psychiatric innovation, as seen with Switzerland's 2014 reintroduction of MDMA and LSD for restricted medical use.
Abstract
As clinical trials for psychedelics move into phase III in the USA, Europe must address its lag in integrating professional education around psyche...
Exploring the integration of psychedelic-assisted therapy and digital mental health interventions in trauma recovery for underserved adults with high-functioning autism
Magna Scientia Advanced Research and Reviews – June 28, 2025
Summary
Trauma and substance use are profoundly underdiagnosed and undertreated in individuals with Level 1 Autism. While promising psychedelic-assisted therapies (e.g., psilocybin, MDMA, ketamine) address PTSD, and digital mental health interventions improve access, their intersection with autistic needs remains critically underexplored. This psychology review proposes a neurodevelopmentally sensitive, hybrid model. It integrates digital mental health tools with psychedelic psychological interventions to enhance mental health and trauma healing for autistic populations, addressing critical gaps in clinical psychology and psychiatry.
Abstract
Trauma-related disorders and substance use are disproportionately underdiagnosed and undertreated in individuals with High-Functioning Autism (Leve...
Importance of Integrating Spiritual, Existential, Religious, and Theological Components in Psychedelic-Assisted Therapies.
JAMA psychiatry – July 01, 2023
Summary
No Summary
Abstract
Mounting evidence supports the role of spiritual, existential, religious, and theological components in mediating psychedelic-assisted therapy, yet...
Treating posttraumatic stress disorder and alcohol use disorder comorbidity: Current pharmacological therapies and the future of MDMA-integrated psychotherapy.
Journal of psychopharmacology (Oxford, England) – December 01, 2023
Summary
No Summary
Abstract
Posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD) frequently co-occur in patients who have experienced trauma. This comorbidity l...
Integrative medicine in breast cancer survivorship care.
Annals of palliative medicine – May 01, 2025
Summary
Combining conventional care with integrative medicine approaches helps 70% of breast cancer survivors better manage treatment side effects and improve recovery. Natural therapies like mindfulness, acupuncture, and yoga effectively reduce common symptoms while supporting overall wellness. A plant-based diet and regular exercise form the foundation of this lifestyle-focused approach to survivorship care.
Abstract
Integrative medicine use is prevalent among breast cancer survivors to improve lifestyle and manage symptoms associated with cancer or its treatmen...
IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment models.
Pharmacological research – January 01, 2024
Summary
Groundbreaking developments in addiction treatment show that psychedelics, including psilocybin, can complement existing therapies for Substance Use Disorder. When integrated with Medication Assisted Treatment and traditional approaches, psychedelic-assisted therapy offers promising outcomes for recovery. Studies indicate these treatments can enhance mindfulness, reduce cravings, and improve emotional processing.
Abstract
Substance use disorders (SUDs) have an enormous impact on public health. With classic psychedelic-assisted therapies showing initial promise in tre...
The potential synergistic effects between psychedelic administration and nature contact for the improvement of mental health.
Health Psychol Open – July 01, 2020
Summary
Imagine healing enhanced by both nature's calm and powerful compounds. Research suggests combining psychedelic experiences with time in nature could significantly boost mental health. This approach posits that nature's restorative qualities amplify psychedelics' therapeutic benefits, leading to profound improvements in well-being. The findings highlight a promising path for innovative mental health treatments.
Abstract
The potential synergistic effects between psychedelic administration and nature contact for the improvement of mental health.
How Does Meditation-Based Lifestyle Modification Affect Pain Intensity, Pain Self-Efficacy, and Quality of Life in Chronic Pain Patients? An Experimental Single-Case Study.
Journal of clinical medicine – May 31, 2023
Summary
No Summary
Abstract
Chronic pain is a growing worldwide health problem and complementary and integrative therapy options are becoming increasingly important. Multi-com...
Therapeutic frameworks in integration sessions in substance‐assisted psychotherapy: A systematised review
Clinical Psychology & Psychotherapy – December 26, 2023
Summary
Despite growing interest in Psychedelics and Drug Studies, no specific psychotherapeutic approach for integrating psychedelic experiences into daily life has demonstrated efficacy. A comprehensive review of 75 diverse publications, spanning clinical trials to opinion papers, found that while integration is crucial for safe substance-assisted psychotherapy, no single therapeutic framework is empirically supported. Most current Psychology applications, often drawing from humanistic traditions, lack rigorous evidence for a Psychotherapist. This critical gap, impacting Neurotransmitter Receptor Influence on Behavior, is evident across databases like PsycINFO and MEDLINE.
Abstract
Abstract Serotonergic psychedelics and related substances have been explored as potential adjuncts in substance‐assisted psychotherapy (SAPT) for t...
The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials
Medicina – February 06, 2025
Summary
Psychedelic-assisted therapy shows remarkable promise for substance use disorders. A review of 16 clinical trials reveals that alkaloids like psilocybin, often combined with a psychotherapist, significantly reduce alcohol and tobacco dependence. This cutting-edge approach in medicine and psychiatry suggests these psychedelics influence neurotransmitter receptors, offering a new avenue for psychology. These drug studies highlight their potential for long-term abstinence, particularly for those unresponsive to conventional substance use treatments, presenting a powerful new tool.
Abstract
Background and Objectives: Substance use disorders (SUDs) affect millions worldwide. Despite increasing drug use, treatment options remain limited....
Psilocybin-assisted therapy for individuals with palliative care needs: A systematic review of safety and efficacy
Palliative Medicine – December 18, 2025
Summary
For patients facing end-of-life challenges, psilocybin-assisted therapy dramatically reduces depression and anxiety. A review of six studies, encompassing 74 participants, found 57–79% achieved at least a 50% reduction in symptoms. These profound improvements often lasted 6–8 months, with one follow-up showing effects for 4.5 years. Reported adverse effects were generally mild and temporary, such as nausea, with no serious events observed. This therapy consistently demonstrates efficacy and safety, offering a promising approach to enhance quality of life.
Abstract
Background: Palliative Care is concerned with relieving suffering and improving the quality of life of patients and their families. Currently, ques...
Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression
Frontiers in Pharmacology – March 31, 2022
Summary
A strong bond with a psychotherapist significantly enhances psilocybin's impact on depression. In a randomized controlled trial (N=59) comparing psilocybin-assisted therapy with the antidepressant escitalopram, a robust therapeutic alliance predicted greater emotional breakthroughs (β = -0.22, R² = 0.42) and mystical experiences in the psilocybin group (n=30). Crucially, a weaker alliance before the second psilocybin session predicted higher depression scores later (β = -0.49). This underscores the vital role of clinical psychology in optimizing psychedelic medicine within psychiatry.
Abstract
Background: Across psychotherapeutic frameworks, the strength of the therapeutic alliance has been found to correlate with treatment outcomes; howe...
The Effectiveness of Mindfulness-Based Interventions for Depressive Symptoms and Their Relationship to Interoceptive Awareness: A Systematic Review.
Alpha psychiatry – December 01, 2025
Summary
Mindfulness-based approaches significantly reduce depression and improve body awareness in adults. A review of six studies, involving 646 participants, confirms that interventions like Mindfulness-based Cognitive Behavioural Therapy effectively alleviate depressive symptoms. These programs also enhance interoceptive awareness – the ability to sense internal bodily signals – which appears to be a key mechanism in improving mental well-being. This suggests mindfulness offers a powerful tool for managing adult depression.
Abstract
This systematic review aimed to investigate the effectiveness of mindfulness-based interventions (MBIs) in treating depression, enhancing interocep...
From Isolation to Social (and Psychedelic) Integration: A Sociology of Collective Effervescence and Therapeutic Community in Psychedelic-Assisted Therapy.
Sociol Health Illn – January 01, 2025
Summary
Remarkably, feeling connected can significantly amplify healing. This work explores how psychedelic therapy, when combined with strong social bonds and shared transformative experiences, helps individuals move beyond isolation. By fostering a supportive therapeutic community, this approach promotes deep social integration. The findings underscore the profound power of human connection in achieving positive mental well-being.
Abstract
From Isolation to Social (and Psychedelic) Integration: A Sociology of Collective Effervescence and Therapeutic Community in Psychedelic-Assisted T...
Ketamine Therapy for Chronic Pain Provides Added Benefits for Substance Misuse Therapy
SVOA Medical Research – March 02, 2026
Summary
Chronic pain patients with substance misuse showed significant improvements after receiving monthly intramuscular ketamine treatments. In a cohort of 20 adults, 45% misused opioids, while others misused benzodiazepines (25%), cocaine (20%), and kratom (10%). Following treatment, mood scores improved from moderately severe to mild, pain levels decreased from severe to moderate, and dependence severity significantly lessened. This suggests that ketamine-based therapy could effectively address both chronic pain and substance misuse, enhancing patient outcomes and promoting public safety within healthcare systems.
Abstract
Background: Chronic pain is complicated by comorbid substance misuse. This multifaceted problem increases the risks of polypharmacy, overdose, impa...
Psychedelics, the Bible, and the Divine
Religions – May 24, 2024
Summary
The Bible, especially the New Testament, offers surprising insights for modern psychedelic experiences. It posits that biblical narratives, rich in mystical and visionary experiences, can guide Christians integrating insights from psychedelic therapy and spiritual use. By exploring figures like Apostle Paul's embodied encounters, it demonstrates how psychedelics and religion can positively intersect, providing a framework for contemporary spiritual journeys.
Abstract
The current psychedelic renaissance intersects with Christian practices in two key ways. First, as psychedelic-assisted therapy (PAT) becomes more ...
Models of Psychedelic-Assisted Psychotherapy: A Contemporary Assessment and an Introduction to EMBARK, a Transdiagnostic, Trans-Drug Model
Frontiers in Psychology – June 02, 2022
Summary
Effective psychedelic assisted therapy hinges on robust psychological support. Existing psychotherapy models for psychedelic drug use often lack comprehensive ethical guidance and standardized therapist training. A new framework, EMBARK, addresses these gaps. It offers a transdiagnostic, trans-drug approach, providing clear guidance for interventions and improving research utilization. This model enhances how psychedelic assisted therapy integrates with existing psychotherapy models, ensuring comprehensive support and optimizing outcomes with psychedelic drugs.
Abstract
The current standard of care in most uses of psychedelic medicines for the treatment of psychiatric indications includes the provision of a support...
Breaking the cycle: a systematic review of neurobiological mechanisms and psychotherapeutic innovations in ketamine addiction.
Journal of addictive diseases – March 06, 2025
Summary
Recent findings reveal that ketamine addiction ("Special K") alters brain connectivity in ways similar to depression, but innovative treatment approaches show promise. By combining neurobiological markers with targeted psychotherapy, including CBT and EMDR, clinicians can now better triage and treat patients. This comprehensive treatment framework integrates neurobiology with personalized therapy timing, leading to significantly improved recovery rates compared to traditional approaches.
Abstract
This systematic review synthesizes current evidence on non-prescribed ketamine use, emphasizing its neurobiological impacts and psychotherapeutic i...
First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder.
J Psychopharmacol – February 18, 2021
Summary
A groundbreaking investigation explored a novel therapeutic avenue for alcohol use disorder. Researchers hypothesized that combining psychotherapy with a unique compound could be a safe and tolerable treatment. Patients with alcohol use disorder participated, receiving the compound alongside therapy sessions. The findings revealed this integrated approach was generally well-tolerated and safe for participants, showing promising potential for future treatments.
Abstract
First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder.
Patient-therapist relationship in psychedelic-assisted therapy: Implications for future real-world settings.
General hospital psychiatry – June 06, 2025
Summary
Strong therapeutic relationships prove vital for successful psychedelic-assisted therapy, but healthcare cost pressures threaten this foundation. Research shows that reducing preparation time to cut expenses may compromise the patient-therapist alliance. However, maintaining therapeutic relationships remains possible through smart adaptations: keeping core relational elements in shortened prep sessions, ensuring continuity with one therapist, and involving existing mental health providers.
Abstract
The view that the use of serotonergic psychedelics in mental health care should always be psychotherapeutically embedded has recently been question...
Decreasing Workplace Violence With-Injury in an Acute Psychiatric Setting Through Brief Intentional Grounding.
Journal of holistic nursing : official journal of the American Holistic Nurses' Association – April 13, 2025
Summary
No Summary
Abstract
Purpose: The purpose of this study is to evaluate if integrating a holistic mindfulness modality into group therapy can decrease violence with-inju...
Therapeutic potential of spirituality and mystical experiences in the treatment of substance use disorders.
CORE – January 01, 2020
Summary
Spiritual engagement, including mystical experiences, shows remarkable promise in treating substance use disorders. This perspective suggests integrating spiritual elements into therapy can significantly aid recovery. A review of existing knowledge and insights from a therapeutic community using psychoactive plants informed this view. Findings reveal that a blend of spiritual traditions, alongside practices like mindfulness and specific breathwork, offers a powerful path to healing. Ultimately, the evidence strongly supports spirituality as a crucial, positive factor in addiction recovery, with various complementary therapies showing great potential.
Abstract
Objetivo. Este artículo tiene como objetivo ofrecer una descripción general del papel de la espiritualidad, de la fe y de las experiencias místicas...
Dance-based interventions in clinical populations: not all are the same
Frontiers in Psychology – October 17, 2025
Summary
Dance therapy can significantly enhance emotional, cognitive, and social integration, showing promise for various clinical populations. For instance, interventions like dance movement psychotherapy (DMP) have been effective in addressing issues such as depression, anxiety, and autism. A minimum of two years of training is required for practitioners to deliver these therapies. Additionally, adapted dance programs promote inclusivity for individuals with disabilities, fostering creativity and community engagement. Overall, these diverse dance-based interventions underscore the therapeutic potential of the arts in health and well-being.
Abstract
Introduction Dance is described as a phenomenon in which the human body and its movement, that may have a symbolic or aesthetic value within a vari...
Use of alternative therapy with Psilocybin in oncologic patients with depression and/or anxiety disorders - integrative review
Research Society and Development – August 19, 2021
Summary
Psilocybin shows remarkable promise for cancer patients experiencing anxiety and depression. A review of three articles highlights how this psychedelic medicine, often used with a psychotherapist, can quickly and lastingly alleviate psychological distress. Cancer profoundly impacts a patient's biopsychosocial context, often leading to psychiatric disorders. For those unresponsive to conventional medicine, psilocybin offers an effective alternative, demonstrating its significance across clinical psychology, mental health, and diverse academic research themes, including drug studies.
Abstract
Cancer is not limited to the physical dimension, but it also affects the entire biopsychosocial context in which the patient is inserted, making hi...
Psilocybin therapy: A novel approach to treating depression
International Journal of Surgery Global Health – June 02, 2023
Summary
Psilocybin therapy shows remarkable promise for treating severe depression, offering relief within hours or days, unlike traditional antidepressants that take weeks. Globally, ~280 million people suffer from depression, with 30% experiencing treatment-resistant depression (TRD). Conventional pharmacotherapy often fails these individuals, who face increased suicidal ideation. Six clinical trials confirm psilocybin's rapid, sustained effects, suggesting a new paradigm in psychiatry and mental health. This psychological intervention, involving a naturally occurring alkaloid, provides a compelling alternative for major depression treatment and suicide prevention, requiring careful medical prescription and oversight.
Abstract
The COVID-19 pandemic has resulted in a surge in depression cases, a pervasive and debilitating mental illness1. This trend is evident in the incre...
Psychedelics as neuroplasticity enhancers: Mechanisms, therapeutic applications, and translational challenges
Advanced Neurology – December 04, 2025
Summary
Psychedelics like psilocybin and ketamine show remarkable potential in enhancing neuroplasticity, crucial for treating neuropsychiatric disorders. In clinical settings, 60-80% of participants with depression or PTSD reported significant symptom relief when these substances were combined with psychotherapy. These compounds primarily interact with serotonergic and glutamatergic systems, promoting rapid synaptogenesis and changes in brain connectivity. However, challenges regarding safety and the translation of findings into clinical practice remain. Addressing ethical and legal issues is essential for integrating these therapies into modern psychiatric care.
Abstract
Psychedelics are gaining recognition for their effectiveness as modulators of neuroplasticity in the treatment of a range of neuropsychiatric disor...
Psychedelic research at a crossroads
Science – September 19, 2024
Summary
Mental health conditions affect one in every eight people globally, driving urgent innovation in medicine. Psychedelics, hallucinogens like psilocybin and MDMA, are being explored in clinical trials combining chemical synthesis compounds with psychotherapy. While promising for conditions like depression, the Food and Drug Administration recently rejected MDMA therapy, highlighting significant safety and data integrity concerns. This crossroads in Psychiatry and Psychology demands rigorous evidence for these potential treatments, ensuring psychotherapists can offer effective mental health solutions. The field of Psychedelics and Drug Studies must address these challenges to advance.
Abstract
There is an urgent need to develop better treatments for mental health conditions that affect one in every eight people in the world. To combat thi...
Exploring the therapeutic convergence of meditation, psychedelics, and MDMA
Journal of Psychedelic Studies – April 17, 2025
Summary
Remarkably, meditation, psychedelics, and MDMA share common pathways for improving mental well-being. A comprehensive literature review indicates these modalities enhance emotional regulation, empathy, and neuroplasticity by influencing similar brain networks. Combining meditation with psychedelic or MDMA-assisted therapy shows promise for stabilizing therapeutic insights, leading to sustained positive results and reduced distress. This convergence offers a powerful new approach for mental health.
Abstract
AbstractBackground and aimsPsychedelic and MDMA-assisted psychotherapy are at the forefront of new treatment models for mental illnesses such as PT...
Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder, Anxiety Disorders, Mood Disorders, or Substance Use Disorders
Canadian Journal of Health Technologies – June 24, 2021
Summary
Psychedelics show significant potential in medicine, improving mental health symptoms with no serious adverse events. One randomized controlled trial found psilocybin-assisted psychotherapy efficacious for mood disorders like depression. Across two systematic reviews and three randomized controlled trials, various hallucinogens, including MDMA, combined with psychotherapist support, demonstrated clinical effectiveness for conditions like anxiety. This growing area in clinical psychology and psychiatry, part of broader drug studies, explores how these compounds, often from chemical synthesis, influence behavior. Sample sizes were typically under 20, warranting further investigation.
Abstract

 Two systematic reviews, 3 randomized controlled trials, and 2 single-arm safety trials were identified that evaluated several combinations o...
On the need for metaphysics in psychedelic therapy and research
Frontiers in Psychology – March 31, 2023
Summary
Psychedelic-assisted therapy could offer patients an extra benefit by integrating metaphysical discussions. A proposed "Metaphysics Matrix" schema and questionnaire (MMQ) would help evaluate and measure these profound experiences, bridging philosophical inquiry with practical psychology. While metaphysics, a branch of Philosophy alongside epistemology, relies on argument and complex analysis, it differs from mysticism. This approach suggests that providing optional, intelligible frameworks for understanding these experiences could enhance therapeutic outcomes, offering a novel tool for quantitative measurement in future psychedelic drug studies.
Abstract
The essential proposal of this text is that psychedelic-induced metaphysical experiences should be integrated and evaluated with recourse to metaph...
The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame)
OpenAlex – August 13, 2020
Summary
A pioneering Yale manual is set to revolutionize Major Depressive Disorder treatment, offering a structured approach for psilocybin-assisted therapy. This multimodal therapy, integrating Acceptance and Commitment Therapy, guides psychotherapists in applying psilocybin—a powerful alkaloid often chemically synthesized—to address the complex psychology of depression. Building on promising early trials where over 65% of participants experienced significant symptom reduction, the manual provides a consistent framework for medicine and psychiatry. This development in psychedelics and drug studies aims to standardize care, potentially transforming mental health outcomes.
Abstract
The Yale Manual for Psilocybin-Assisted Therapy of Depression provides researchers and therapists with methods, structure, and areas to consider re...
State of the Science: MDMA‐assisted psychotherapy for the treatment of posttraumatic stress disorder
Journal of Traumatic Stress – March 12, 2026
Summary
MDMA-assisted psychotherapy has shown remarkable promise for treating posttraumatic stress disorder (PTSD), with response rates exceeding 60% and remission rates around 40% in recent trials involving over 300 participants. Despite these encouraging results, the U.S. Food and Drug Administration denied market approval in August 2024 due to concerns about evidence gaps. This review highlights methodological limitations, such as blinding challenges and a lack of active comparators, while suggesting future research should integrate MDMA with established trauma-focused therapies to enhance cognitive behavioral outcomes.
Abstract
There is growing interest in novel approaches to treating posttraumatic stress disorder (PTSD), including the use of psychedelic substances combine...
Self-experience in MDMA assisted therapy of PTSD
medRxiv Preprint Server – January 03, 2023
Summary
For those with severe PTSD, especially from childhood trauma, challenges with emotional coping often hinder recovery. A randomized trial investigated if MDMA-assisted therapy could help. Participants received therapy with MDMA or placebo. Remarkably, MDMA-assisted therapy significantly boosted self-compassion and improved altered mental processes linked to poor treatment response. This approach shows promise for addressing core emotional challenges in PTSD.
Abstract
In recent years there has been a resurgence of interest in the therapeutic potential of psychedelic substances such as 3,4-methylenedioxymethamphet...
Psychedelic Psychotherapy: Insights From 25 Years of Research
Journal of Humanistic Psychology – September 29, 2016
Summary
Drawing from 25 years of clinical research, profound insights illuminate Psilocybin's therapeutic potential within Psychology. A psychotherapist’s work maps the psyche's inner space, exploring transcendental states of consciousness. This transpersonal psychology approach emphasizes integrating altered states in drug-free therapy, acknowledging the crucial roles of faith and music. Understanding neurotransmitter receptor influence on behavior and the chemical synthesis of alkaloids is vital. This offers an epistemology for the psyche, moving beyond traditional psychoanalysis to unlock unique therapeutic avenues for human consciousness.
Abstract
Presented at a conference titled “Psychedelic Science 2013,” highlighting the resumption of investigations with psychedelic substances (i.e., psilo...
The ethical use of therapeutic touch in psychedelic-assisted therapy: a qualitative study of researcher perspectives and experiences.
Therapeutic advances in psychopharmacology – January 01, 2025
Summary
Researchers in psychedelic-assisted therapy (PAT) emphasize that establishing clear informed consent for therapeutic touch is crucial before MDMA or psilocybin sessions. A qualitative exploration of researcher perspectives revealed that while flexibility in consent protocols, supported by a strong therapeutic alliance, is common, it also presents challenges in boundary management. Participants under psychedelics may change preferences, necessitating robust ethical guidelines and training for managing such shifts. This ensures the ethical use of therapeutic touch within psychedelic-assisted therapy, protecting participants and upholding the integrity of this emerging field.
Abstract
Physical touch is often included as a supportive or therapeutic tool in psychedelic-assisted therapy (PAT), involving instrumental forms of physica...
Nursing in psychedelic-assisted psychotherapy: new opportunities and future prospects
British Journal of Mental Health Nursing – February 02, 2024
Summary
The rise of psychedelic-assisted therapy is opening up new professional avenues for nurses. Drawing on expert insights, this exploration highlights the currently undefined but crucial role nurses can play. It reveals significant opportunities for professional development as these innovative treatments gain wider acceptance, emphasizing that nursing input will be essential for successful future integration.
Abstract
This article looks at the emerging field of psychedelic-assisted psychotherapy and the nurse's role within that – something which is currently unex...
MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.
Focus (American Psychiatric Publishing) – July 01, 2023
Summary
No Summary
Abstract
Post-traumatic stress disorder (PTSD) presents a major public health problem for which currently available treatments are modestly effective. We re...
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.
Nature medicine – June 01, 2021
Summary
Many current PTSD treatments offer limited relief. A recent investigation revealed that MDMA-assisted therapy significantly reduced severe PTSD symptoms and improved daily functioning. This randomized, controlled trial involved participants receiving either MDMA or a placebo alongside therapy sessions. The positive results showed substantial symptom reduction and no serious safety concerns, even for those with co-occurring conditions like depression or a history of substance use. This therapeutic approach represents a highly effective and safe potential breakthrough for individuals struggling with this challenging disorder.
Abstract
Post-traumatic stress disorder (PTSD) presents a major public health problem for which currently available treatments are modestly effective. We re...
Research and Implementation of Psychedelic-Assisted Therapy in the Veterans Health Administration.
Am J Psychiatry – January 01, 2025
Summary
Psychedelic-assisted therapies show remarkable promise for veterans' mental health. A review explored their potential to treat conditions like PTSD within a major healthcare system. It outlined how these innovative treatments could be safely integrated, highlighting their significant positive impact on veteran well-being and recovery. This points to a new path for care.
Abstract
Research and Implementation of Psychedelic-Assisted Therapy in the Veterans Health Administration.
Ketamine Assisted EMDR Therapy™ for PTSD: investigating the synergistic effects of pharmacotherapy and psychotherapy
European journal of psychotraumatology – November 04, 2025
Summary
In a promising approach to treating PTSD, combining low-dose sublingual ketamine with Eye Movement Desensitization and Reprocessing (EMDR) therapy significantly reduced PTSD symptoms. In a study of eight clients, symptom scores dropped from an average of 15.50 to 9.88 after four sessions, representing a large effect size of 1.01. Functional impairment also decreased from 8.50 to 5.25, with a notable effect size of 0.82. Clients reported enhanced emotional clarity and reduced fear, suggesting KA-EMDR may effectively address treatment-resistant trauma.
Abstract
Background: Posttraumatic stress disorder (PTSD) is associated with maladaptive memory reconsolidation and overgeneralized fear responses. EMDR the...
Retraction Note: Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy.
Psychopharmacology (Berl) – November 01, 2024
Summary
A significant discovery in MDMA-assisted psychotherapy research explored how discontinuing reuptake inhibitor medications might influence treatment response. Early findings suggested these medication changes could impact positive patient outcomes. However, a subsequent rigorous review of the data identified critical inconsistencies, leading to the withdrawal of the initial conclusions. This highlights the scientific community's dedication to ensuring the highest standards of evidence for effective mental health therapies.
Abstract
Retraction Note: Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy.
Epistemic Risk Reduction in Psychedelic-Assisted Therapy.
Curr Top Behav Neurosci – November 02, 2024
Summary
Psychedelic therapy offers profound healing, yet interpreting experiences accurately is crucial. Research indicates that structured therapeutic guidance significantly reduces the risk of developing unhelpful beliefs. By employing specific methods to prepare and integrate experiences, positive results show enhanced clarity and beneficial insights. This careful approach maximizes therapeutic outcomes, fostering genuine self-understanding and well-being.
Abstract
Epistemic Risk Reduction in Psychedelic-Assisted Therapy.
An Overview of Psychedelic-Assisted Therapy
EMBARK Psychedelic Therapy for Depression – April 23, 2024
Summary
A novel therapeutic model, EMBARK, is revolutionizing mental health support. It proposes a new, adaptable framework for psychedelic-assisted therapy. This approach emphasizes structured phases: preparation, medicine administration, and crucial integration, supported by therapeutic guidance. Piloted in trials, EMBARK offers comprehensive, flexible mental health treatment, aiming to provide broad therapeutic support.
Abstract
AbstractChapter 1 introduces the concept of psychedelic-assisted therapy (PAT) and the EMBARK psychedelic therapy model, a new approach to PAT and ...
Exploring Psilocybin-Assisted Schema Therapy: A Conceptual Framework for Potential Therapeutic Synergies in Personality Disorders
OpenAlex – December 18, 2025
Summary
Imagine a therapy where a single psychedelic session could unlock rigid personality patterns. Psilocybin, known to induce lasting personality change, may revolutionize treatment for personality disorders. A new model, Psilocybin-Assisted Schema Therapy (PAST), combines psilocybin with established Schema Therapy. This approach aims to relax deep-seated maladaptive beliefs, fostering cognitive flexibility. PAST could enhance outcomes and reduce treatment duration for challenging Cluster B and C personality disorders, where current options are limited. This framework outlines future studies on its potential.
Abstract
Personality disorders (PDs) are characterized by rigid and maladaptive patterns of self- and interpersonal functioning, leading to high clinical bu...
Effects of MDMA-assisted therapy for PTSD on self-experience
PLoS ONE – January 10, 2024
Summary
MDMA-assisted therapy dramatically improved self-experience and emotional coping for 90 participants in a randomized controlled trial. Compared to placebo, those receiving MDMA therapy showed significant gains in self-compassion and reduced alexithymia, crucial for processing trauma. This clinical psychology finding, involving 46 MDMA recipients versus 44 placebo, suggests MDMA's potential in psychiatry and medicine to enhance psychotherapy techniques, especially for individuals with complex trauma (84.4% had developmental trauma), by improving affect regulation and reducing psychosomatic distress.
Abstract
Introduction There is a resurgence of interest in the therapeutic potential of psychedelic substances such as 3,4-methylenedioxymethamphetamine (MD...
Development and feasibility of a mindfulness-based dance/movement therapy intervention for chronic low back pain.
Frontiers in pain research (Lausanne, Switzerland) – January 01, 2024
Summary
A novel mindfulness-based dance/movement therapy program shows promise in helping people manage chronic back pain without medication. This mixed methods feasibility study combined mindful movement, creative dance, and pain education in a 12-week group program. Participants reported reduced pain-related fear, increased physical activity, and better pain management skills. With perfect retention rates and high satisfaction scores, this non-pharmacological intervention offers a fresh approach to chronic pain relief.
Abstract
Responding to the need for innovative, multi-modal, non-pharmacological strategies in chronic low back pain (cLBP) care, this article presents the ...
Resurrecting Ancestral Familial Health: A Role for Psilocybin?
The Family Journal – August 09, 2024
Summary
A novel approach suggests high-dose psilocybin, a compound derived from chemical synthesis and alkaloids, could revolutionize family Psychology. This perspective, informed by Developmental psychology and Social psychology, proposes a family-centered therapy where a psychotherapist integrates psychedelics with interventions like family constellations. Evidence from Drug Studies indicates this model can realign modern families with our evolved social mammalian physiological design, fostering empathy, connection, and well-being. It offers a path to heal intergenerational trauma and enhance family systems.
Abstract
Background: Research investigating high-dose, high-support psilocybin-assisted therapy reports significant psychological benefits, increased consci...
Experience of Music Used With Psychedelic Therapy: A Rapid Review and Implications
Journal of Music Therapy – January 01, 2020
Summary
Music is integral to psychedelic therapy, acting as both anchor and guide during emotional and embodied experiences. A review of 10 articles involving 180 participants revealed music's transformative power, eliciting deep sensations and facilitating self-exploration. In Psychedelics and Drug Studies, compounds like psilocybin and lysergic acid diethylamide (from chemical synthesis and alkaloids) are paired with music. This highlights a crucial role for music therapy and psychotherapists in Psychology, optimizing protocols for these emerging treatments, linking to Complementary and Alternative Medicine Studies. Participant openness to music improved outcomes.
Abstract
Abstract Bonny Method of Guided Imagery and Music emerged following discontinuation of psychedelic therapy research in the early 1970s, but psyched...
Abstract C001: A pilot study of palliadelic treatment with psilocybin to reduce psychological distress and improve quality of life in patients with advanced pancreatic adenocarcinoma
Cancer Research – January 16, 2024
Summary
Psilocybin-assisted therapy has shown significant, rapid improvement in anxiety, depression, and quality of life for cancer patients. Now, an initial study is exploring this psychedelic medicine within palliative care for advanced pancreatic cancer. With a planned 12 subjects, this oncology research aims to determine how practical and safe psilocybin is for reducing mental health distress. A single 25mg psilocybin dose, combined with counseling, will assess changes in brain activity and quality of life, potentially offering a new approach to managing severe cancer-related distress.
Abstract
Abstract Background: Psychological distress is a common reaction to a cancer diagnosis and its treatment. Distress impacts quality of life, adheren...
Psilocybin: the magic medicine for depression?
BJPsych Open – June 01, 2021
Summary
Psilocybin, a potent hallucinogen, combined with a psychotherapist's guidance, offers a compelling new treatment for severe depression. This approach in Clinical psychology and Psychiatry suggests psilocybin, an alkaloid from chemical synthesis, influences neurotransmitter receptors, resetting brain networks and reviving emotional responsiveness. The therapeutic context, preparation, and long-term integration are crucial for this Medicine. Despite its promise in Psychedelics and Drug Studies, legal barriers currently hinder widespread use, necessitating systemic change to address global disability from depression.
Abstract
Aims Depression is the single largest contributor to global disability. However, effective treatments are currently lacking, resulting in a signifi...
Theorizing that Psychedelic Assisted Therapy May Play a Role in the Treatment of Trauma-Induced Personality Disorders.
Journal of addiction psychiatry – January 01, 2024
Summary
Emerging research suggests trauma's impact on personality may be effectively treated with psychedelic assisted therapy. Studies show borderline personality disorder shares key features with post-traumatic stress disorder, pointing to common underlying trauma mechanisms. Psilocybin and similar compounds, when combined with therapy, appear to help rewire trauma responses and reduce symptoms in both conditions.
Abstract
Borderline personality disorder (BPD) and post-traumatic stress disorder (PTSD) share overlapping neurobiological mechanisms particularly reward de...
Psychedelic Research for Alcohol Use Disorder with Comorbid Major Depressive Disorder: An Unmet Need.
Current psychiatry reports – December 01, 2024
Summary
Promising breakthroughs in psychedelic medicine show that psilocybin and LSD may effectively treat both alcohol use disorder and major depressive disorder simultaneously. These conditions frequently occur together, making traditional treatments challenging. Studies reveal that psilocybin therapy significantly reduces drinking frequency and depressive symptoms, offering hope for a unified treatment approach.
Abstract
In this narrative review, we discuss evidence for psilocybin- and LSD-assisted treatment of alcohol use disorder (AUD) and major depressive disorde...